Closed
SectorHealthcare
34.6 4.78
24h
Min
32.65
Max
34.7
Income | -103M -267M |
---|---|
Sales | 3.2M 5.9M |
EPS | -1.374 |
Profit margin | -4,545.886 |
Employees | 725 |
EBITDA | -95M -235M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +66.78% upside |
Next Earnings | 1 May 2025 |
---|
Market Cap | -30M 6.7B |
---|---|
Previous open | 29.82 |
Previous close | 34.6 |
By Acuity
12%
88%
14 / 386 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 55.07 USD 66.78%
High 95 USD
Low 37 USD
Based on 17 Wall Street analysts offering 12 month price targets forBridgebio Pharma Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$